Iradimed Stock Surges as Record Quarterly Revenue Streak Hits 18

Life Science

Revenue Highly Dependent on the GLP-1 Track: How Does Lilly Balance Growth and Risk?

Life Science

Hims & Hers Stock Plunges 25% After Abandoning Copycat Wegovy Pill

Life Science

Novo Nordisk Crashes 68%: Is It Time to Buy the Dip?

Life Science

Biogen’s Financial Report and Outlook Exceed Expectations, Stock Soars Nearly 9% on Friday 

Life Science

Amazon Begins Selling Oral Weight-Loss Drug Wegovy, Intensifying Competition in the GLP-1 Retail Market

Life Science

Why Did This Pharma Stock Defy the Market Downturn Today?

Life Science

6 Top Healthcare Stocks to Buy Now, According to Analysts

Life Science

Weight Loss Drug Giant Eli Lilly’s Market Cap Surges Nearly $100 Billion, Accelerating Expansion into New Gene Therapy Sector 

Life Science

Where Is the Market Heading in 2026?

Life Science

Stock Plunges Nearly Half in a Year! UnitedHealth Group Faces Double Whammy 

Life Science

Pfizer Obesity Drug Data Triggers Sell-Off: Buy or Sell the Dip?

Life Science

Can Pfizer Stage a Comeback in 2026?

Life Science

Don’t Miss Out on These Three “High-Potential Stocks”!

Life Science, Technology

AI in Action: How Healthcare Giant HCA Is Using Technology to Improve Care and Efficiency

Life Science, Technology